Alnylam Pharmaceuticals
ALNY
₹24,115
Share price
-3.35%
Change (1 day)
90.10%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Market capitalization of Alnylam Pharmaceuticals (ALNY)
Market cap: ₹3.121 Trillion
As of March 2025 Alnylam Pharmaceuticals has a market cap of ₹3.121 Trillion. This makes Alnylam Pharmaceuticals the world's 564th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Alnylam Pharmaceuticals from 2004 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | ₹3.121 T | 18.53% |
| 2024 | ₹2.633 T | 31.68% |
| 2023 | ₹1.999 T | -17.35% |
| 2022 | ₹2.419 T | 60.27% |
| 2021 | ₹1.509 T | 36.7% |
| 2020 | ₹1.104 T | 19.85% |
| 2019 | ₹921.38 B | 78.63% |
| 2018 | ₹515.80 B | -35.88% |
| 2017 | ₹804.49 B | 268.48% |
| 2016 | ₹218.33 B | -58.99% |
| 2015 | ₹532.33 B | 12.16% |
| 2014 | ₹474.61 B | 87.44% |
| 2013 | ₹253.21 B | 382.76% |
| 2012 | ₹52.45 B | 184.73% |
| 2011 | ₹18.42 B | -1.54% |
| 2010 | ₹18.70 B | -45.3% |
| 2009 | ₹34.20 B | -30.52% |
| 2008 | ₹49.22 B | 5.79% |
| 2007 | ₹46.53 B | 32.51% |
| 2006 | ₹35.11 B | 202.91% |
| 2005 | ₹11.59 B | 85.84% |
| 2004 | ₹6.23 B |
End of Day market cap according to different sources
On Mar 25th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | ₹173.60 B | -94.44% | 🇺🇸 USA |
 | ₹5.950 T | 90.65% | 🇺🇸 USA |
 | ₹613.04 B | -80.36% | 🇺🇸 USA |
 | ₹103.75 B | -96.68% | 🇺🇸 USA |
 | ₹7.39 B | -99.76% | 🇺🇸 USA |
 | ₹18.794 T | 502.18% | 🇨🇭 Switzerland |
 | ₹11.824 T | 278.85% | 🇫🇷 France |
 | ₹1.549 T | -50.36% | 🇮🇱 Israel |